Tamoxifen has been widely used in the treatment of breast cancer. We report 4 patients who developed some of the iatrogenic gynaecological complications associated with tamoxifen treatment. All patients presented with postmenopausal bleeding and their endometrial pathologies included endometrial hyperplasia, endometrial polyp and endometrial carcinoma. Clinicians should be aware of this association and prompt investigation is needed in postmenopausal women taking tamoxifen when symptoms occur.link_to_subscribed_fulltex
Tamoxifen, a selective estrogen receptor modulator, is widely used as adjunctive therapy for women w...
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It...
Tamoxifen plays a critical role in the treatment of hormone receptor-positive breast cancer. Despite...
The aim of this retrospective study was to detect endometrial lesions in tamoxifen breast cancer use...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...
Background: Although tamoxifen has well documented oestrogen-like effects in the endometrium and ect...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
INTRODUCTION: Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
Since large trials have been set up to assess whether tamoxifen decreases the risk of breast cancer ...
To describe the endometrial appearance in postmenopausal breast cancer patients on tamoxifen and to ...
A Case of hyperestradiolemia induced by Tamoxifen was reported. A 37-year old woman presented with r...
OBJECTIVE: To determine the effect of tamoxifen on the endometrium in postmenopausal women with brea...
WOS: 000078321800017PubMed ID: 10215447Objective: To investigate the effects of tamoxifen on the end...
yahoo.com We present a case of adenomatous polyp with degenerative changes causing abnormal postmeno...
Tamoxifen, a selective estrogen receptor modulator, is widely used as adjunctive therapy for women w...
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It...
Tamoxifen plays a critical role in the treatment of hormone receptor-positive breast cancer. Despite...
The aim of this retrospective study was to detect endometrial lesions in tamoxifen breast cancer use...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...
Background: Although tamoxifen has well documented oestrogen-like effects in the endometrium and ect...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
INTRODUCTION: Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
Since large trials have been set up to assess whether tamoxifen decreases the risk of breast cancer ...
To describe the endometrial appearance in postmenopausal breast cancer patients on tamoxifen and to ...
A Case of hyperestradiolemia induced by Tamoxifen was reported. A 37-year old woman presented with r...
OBJECTIVE: To determine the effect of tamoxifen on the endometrium in postmenopausal women with brea...
WOS: 000078321800017PubMed ID: 10215447Objective: To investigate the effects of tamoxifen on the end...
yahoo.com We present a case of adenomatous polyp with degenerative changes causing abnormal postmeno...
Tamoxifen, a selective estrogen receptor modulator, is widely used as adjunctive therapy for women w...
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It...
Tamoxifen plays a critical role in the treatment of hormone receptor-positive breast cancer. Despite...